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We report a single-walled carbon nanotube (SWNT) field-effect transistor (FET) functionalized
with Polyamidoamine (PAMAM) dendrimer with 128 carboxyl groups as anchors for site specific
biomolecular immobilization of protein antibody for C-reactive protein (CRP) detection. The FET
device was characterized by scanning electron microscopy and current-gate voltage (I-Vg) charac-
teristic studies. A concentration-dependent decrease in the source-drain current was observed in the
regime of clinical significance, with a detection limit of 85 pM and a high sensitivity of 20%
change in current (DI/I) per decade CRP concentration, showing SWNT being locally gated by the
binding of CRP to antibody (anti-CRP) on the FET device. The low value of the dissociation constant
(Kd¼ 0.316 0.13lg ml1) indicated a high affinity of the device towards CRP analyte arising due to
high anti-CRP loading with a better probe orientation on the 3-dimensional PAMAM structure.
Published by AIP Publishing. [http://dx.doi.org/10.1063/1.4972110]
C-reactive protein (CRP) is an acute phase pentameric
plasma protein, consisting of five identical 23 kDa homolo-
gous subunits, which are non-covalently associated in a
cyclic form. It is synthesized by the liver1 and widely
accepted as a biomarker of cardiovascular diseases and
inflammation.2–4 The American Heart Association and the
United States Centre for Disease Control have suggested
three different levels of CRP concentrations for the evalua-
tion of cardiovascular disease risk.5–8 CRP concentration
less than 1 lg ml1 represents a low risk state; concentration
between 1 and 3lg ml1 is considered as an average risk
state; and any CRP concentration above 3 lg ml1 represents
a high risk state. Currently, a number of CRP testing meth-
ods are available in clinical laboratories, such as nephlomet-
ric,9 turbidimetric,10 visual agglutination,11 and the enzyme-
linked immunosorbent assay (ELISA) kits.12 However, these
methods are time-consuming, cost-ineffective, and are not
readily applicable for the rapid point-of care analysis.13 CRP
quantification methods based on surface plasmon resonance
(SPR),14 microfluidics,15 and electrochemistry16 have been
developed during the past few years. However, majority of
these techniques require labels, expensive equipment, and
well-trained personnel. Therefore, a more straightforward
methodology 17,18 with features of (i) high sensitivity and
specificity; (ii) non-labeling method; (iii) rapid assays; and
(iv) portable, disposable, and low cost is needed.
Single-walled carbon nanotubes (SWNT) have been
extensively used as an effective transducer for the fabrication
of highly sensitive field-effect transistor (FET) sensors
because of their ultra high surface area to volume ratio,
extreme electrical (conductance/resistance) sensitivity to
absorption/perturbation of analyte molecule on its surface,
and its facile surface modification possibilities.19 A major
barrier for using SWNTs in nano and microelectronics appli-
cations has been associated with the difficulties in assem-
bling the SWNTs precisely into small devices for scalable
fabrication. This has been overcome by the use of random
network of SWNTs for large area microelectronics devices,
which exhibits the average properties of a large number
of random individual SWNTs. In this work, we report a sig-
nificant improvement in the performance of FET device
fabricated with SWNTs networks between 3lm gap inter-
digitated 10 pairs of gold microelectrodes array on SiO2/Si,
for the quantitative detection of CRP in Phosphate Buffer
Saline (PBS). Further, to facilitate and to improve the density
of the biorecognition molecule, the SWNTs networks were
functionalized with Polyamidoamine (PAMAM) dendrimer
of generation 4.5 (G-4.5) with 128 carboxyl groups as
anchors. The relatively high density of carboxyl group in G-
4.5 PAMAM ensures the incorporation of a large number of
protein antibodies (anti-CRP) through carbodiimide coupling
reaction on the SWNTs network surface for immunoreaction
(antibody-antigen complex formation) with target protein
CRP, producing a major decrease in the source-drain current,
resulting to a high sensitivity Bio-SWNT-FET device.
Therefore, the prime novelty of the manuscript is to highlight
the significance of using G-4.5 PAMAM for the site specific
biomolecular immobilization of protein antibody, anti-CRP,
which provides a favorable microenvironment for the immu-
noreaction for antigen-antibody conjugation with a high out-
put current response than earlier reported FET devices for
CRP detection.20–22 This electronic immunosensor has addi-
tional advantages of being compatible with a low-cost and
scalable fabrication procedure for the label-free detection of
CRP biomarker.
The device is schematically presented in Fig. 1. The sen-
sor fabrication, performance, and sensing mechanism were
investigated by the measurement of the current as a function
of the back-gate voltage (IVg) characteristics.
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The SWNTs network was constructed on a 3-
aminopropyltriethoxy silane (APTES) treated 3lm gap
interdigitated gold microelectrodes array on SiO2/Si (see
details in the supplementary material). The scanning electron
micrograph (FE-SEM, SUPRA 40 VP, Germany) image
shows the high density of the SWNTs network (65
SWNTs/lm2) between the electrodes (Fig. 1). The SWNTs
network was first modified with the bifunctional linker, 1-
methyl pyrene amine, PyMeNH2, (PMA) by incubating it
with 6mM PMA in methanol for 2 h at room temperature,
washed with methanol, and dried under N2 flow. The 1mM
aqueous PAMAM was treated with 0.1M N-(3-dimethyl
aminopropyl)-N0-ethyl carbodiimide hydrochloride (EDC)
and 0.05M N-hydroxy succinimide (NHS) for 3 h to activate
the terminal carboxyl groups of PAMAM into the corre-
sponding NHS-esters. The resultant activated PAMAM was
dispensed over the PMA functionalized SWNTs network,
where the part of the activated NHS-ester binds with the pri-
mary amine of PMA over the surface of the PMA/SWNT-
FET device. The AFM (Nanoscale 8, Bruker) image of the
PAMAM modified SWNT-FET shows many randomly
deposited globular shaped molecules over the SWNT surface
(Fig. S1; see supplementary material). There are a few large
irregular clusters perhaps caused by dendrimer aggregation.
This is reflected by the height profiles of the globular par-
ticles on SWNT, which lie mostly about 6–8 nm with 1–2 nm
diameter size SWNTs, which is consistent with 4.5 nm size
diameter of the PAMAM dendrimer. Similar images have
been obtained earlier for samples on mica substrates.23 The
residual active NHS esters of the PAMAM dendrimer were
bound to amines of anti-CRP during incubation of the
PAMAM/PMA/SWNT-FET device with 100 lg ml1 anti-
CRP protein, for a period of 3 h, in phosphate buffer (PBS;
pH 7.4) at 4 C to obtain the desired anti-CRP-PAMAM/
PMA/SWNT-FET device.
We measured the I–Vg characteristic of each device in
an array of interdigitated 5 SWNT-FETs fabricated on a sin-
gle chip, before and after successive steps of (1) SWNTs
modification with PMA, (2) PAMAM functionalization of
PMA/SWNT-FET device, and (3) bio-functionalization with
anti-CRP to confirm the formation of the bio-SWNT-FET
devices (Fig. S2; see supplementary material). The Au source
and drain electrodes were passivated with an 6-mercapto-1-
hexanol (MCH) self-assembled monolayer to avoid undesired
Au surface contamination with anti-CRP protein during bio-
functionalization. The electrical measurements were recorded
using Agilent B 2902A connected to a Micromanipulator
model 450PM-B probe station by sweeping the gate voltage
from630V at source-drain bias of (Vds) of 100mV. The com-
parison of transistor characteristics of 5 devices revealed a
high conduction to a comparatively denser SWNTs network,
wherein source-drain current decreases strongly with increas-
ing gate potential showing a p-type semiconducting behavior
of the device (transport is dominated by holes) due to the elec-
tron withdrawal of the adsorbed oxygen molecules from the
air.24 However, the devices does not show high on/off ratio,
which may be due to the deleterious inter-CNT interaction in
more densely packed arrays, as evident in the SEM image,
which cause screening effects that decreases both the conduc-
tance and the on/off current ratio.25,26 The drain current contin-
ues to rise with increasing gate voltage without reaching a
saturation, which may be due to the “source exhaustion,” and
the presence of carriers in the metal at energies within the
CNT band gap causes tunneling to the channel through evanes-
cent states in the CNT.27 The SWNT-FET devices show
device to device (n¼ 5) hysteresis of 26 0.7V between the
forward and the reverse direction. This hysteresis is attributed
to charge traps in bulk SiO2, oxygen-related defect trap sites
near nanotubes, or at the SiO2/Si interface.
28
The charge mobility (l) of the devices was estimated
using a standard expression for mobility,29 l ¼ L gm/WCVds,
where L represents the length of the channel, W is the width
of the channel, gm is the transconductance of dI/dV deter-
mined from each transfer characteristics in the linear regime,
Vds is the source-drain voltage, C is the approximate capaci-
tance, C¼ ee0/Lox where e is the dielectric permittivity of
SiO2 (e¼ 3.9) and Lox is the thickness of the SiO2 layer.
The value of C for 300 nm thick SiO2 layer is 12 nF cm2,
which slightly overestimates the gate capacitance and corre-
spondingly underestimates the carrier mobility due to the
lower fill factor.30 The estimated mobility of the 5 SWNT-
FET devices was found to be in the range of 35 to 65 cm2
V1 s1 (Fig. S2(a)). These variations in charge mobility are
expected to depend on the device SWNTs network density as
high density network renders a high mobility31 due to the
availability of more paths for electron transport. After modifi-
cation of SWNTs network with PMA, the threshold voltage
(VTh) shifted towards the lower voltage direction with
the decrease in the source-drain current and reduced
charge mobility ranging between 7 and 20 cm2 V1 s1
(Fig. S2(b)). This is attributed to the binding of PMA with
SWNTs via p–p linkage through pyrene moiety, where an
increased scattering by the basic NH2 reduces the hole density
in the SWNT channel.32 A further decrease in charge mobility
was found (3 to 16 cm2 V1 s1) with a major negative
shift in the VTh due to the increased scattering on SWNTs by
the NHS-ester activated PAMAM dendrimer in PAMAM
modified SWNT-FET devices (Fig. S2(c)). The activated
NHS-ester sites on the PAMAM/SWNT-FET device upon
covalent binding with the protein antibody, anti-CRP, resulted
FIG. 1. Schematic illustration of the PAMAM modified SWNT-FET biosen-
sor device with the SEM image of SWNT network between 3 lm apart gold
source-drain electrodes.
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in a further decrease in the charge mobility (2 to 11 cm2
V1 s1) due to the charge transfer from the electron donating
amine groups of arginine and lysine amino acids presents in
the outer backbone chain of anti-CRP, where each amine
group donates 0.04 electrons33 to the nanotubes and hence
reduces the hole density in the SWNT channel (Fig. S2(d)). A
slight decrease in the charge mobility was obtained after
blocking the uncovered non-specific sites on the SWNTs net-
work and unbound free NHS-ester sites on PAMAM with a
blocking reagent (BR; 0.1% Tween-20 þ 0.1% BSA).26 The
comparative electrical performance of an individual SWNT-
FET device (D1) with respective changes in both VTh and l
after the successive modifications, as discussed previously, is
shown in Figs. 2(a) and 2(b). The substantive changes have
been observed in charge density (q) upon modification of the
SWNT-FET device estimated by the equation29 q¼C DVTh/e
L, where DVTh is the change in the threshold voltage.
The SWNT device show a negative shift in VTh with a
decrease in the hole density of 280 108cm1 for pyrene
modified SWNT-FET with respect to bare SWNT-FET and
384 108cm1 for PAMAM dendrimer modified SWNT-
FET w.r.t. pyrene/SWNT-FET. This large decrease in the hole
density on modification of SWNT-FET with PAMAM den-
drimer reflected the high electron doping of SWNT from the
negatively charged 128 carboxyl groups anchors, confirming
the formation of PAMAM/SWNT-FET device. A further
decrease of 36 108cm1 for anti-CRP-FET w.r.t. PAMAM
modified SWNT-FET clarifies the scattering/charge transfer
characteristics as discussed earlier. Figure 2(c) shows the out-
put and transfer characteristics of the Bio-FET with the I-Vg
curve for Vds¼ 0.1V to 1.0V and I-Vds curves (inset) mea-
sured for Vg¼10V to 30V. The I-Vg shows that the gate
modulates the source-drain current by an increment of 2.5
times with a step of Vds¼ 0.5V and also the linear
relationship between the I-Vds illustrates Ohmic contact
between the SWNT and Au electrodes. In order to investigate
the time period required for the completion of immunoreaction
between the CRP analyte and anti-CRP on the channel surface
of the Bio-FET device, we carried a real-time measurement of
source-drain current upon exposure to 1.0 lg ml1 target ana-
lyte CRP at Vds¼ 0.1 V and Vg ¼ 0 V (the inset of Fig. 2(d):
upper-left side). A sharp decrease in the source-drain current
with a gradual saturation at about 10 min, indicated a near
completion of the immunoreaction between the CRP and anti-
CRP and thus was used as immunoreaction incubation time.
Rest, all the sensing operation has been done only at a fixed
gate voltage of Vg ¼30 V.
To test the sensing performance of the device, a 5 ll
droplet of PBS containing CRP at a known concentration
was dispensed on the sensor device and left to incubate for
10min in humid environment, followed by washing with DI
water, drying under gentle N2 flow, and the measurement of
I–Vg characteristic was taken. A significant decrease in
source-drain current was observed for both the PBS contain-
ing 1.0 and 10 lg ml1 CRP (Fig. 2(d)) and also for the
0.05 lg ml1 CRP (inset of Fig. 2(d): lower-right side), indi-
cating an effective immunoreaction taking place between
anti-CRP and CRP analyte on the sensor device. This is
probably due to increased carrier scattering and/or charge
transfer from the electron donating amino groups of the tar-
get CRP analyte upon its binding to anti-CRP on the SWNT
walls of FET device, as reported earlier.34 On the other hand,
the exposure to pure PBS did not produce much change in
the source-drain current (inset of Fig. 2(d): upper-right side).
Figure 3 depicts the plot of the percentage decrease in
the ON state current at Vg¼30V and Vds¼ 0.1V normal-
ized by the initial current (DI/I) versus CRP concentration in
a logarithmic scale. Each data point in the plot was generated
FIG. 2. (a) Current–gate voltage
(I–Vg) characteristics of a representa-
tive SWNT-FET device, D1 (CNT-
FET) and after its successive chemical/
bio-functionalization, i.e., M1 (PMA/
CNT), M2 (PAMAM/PMA/CNT), M3
(anti-CRP-PAMAM/PMA/CNT) and
M4 [(BR)anti-CRP-PAMAM/PMA/
CNT] Bio-FET; Inset shows the mag-
nified view of the transfer characteris-
tics. (b) Hole mobility of the device
before and after each modification steps;
The inset shows the threshold voltage of
the corresponding device after each
modification. (c) Current–gate voltage
(I–Vg) characteristics of the Bio-FET at
Vds¼ 0.1 to 1.0V; (d) I–Vg of device for
1.0lg ml1 and 10lg ml1 CRP; Insets
show: response for 0.05lg ml1 CRP
(lower right side); the real-time sensor
response to 1.0lg ml1 CRP (upper left
side), and sensor response to pure
10 103 M PBS (upper right side).
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by averaging the responses of 5 anti-CRP functionalized
SWNT-FET devices tested against a solution with the same
concentration of CRP; the error bar shown is the standard
error of the mean. The sensor responses agree well with a
model based on the Hill–Langmuir equation for equilibrium
protein binding35 DI/I¼ [A (c/Kd)n/{1þ (c/Kd)n}]þZ, where
c is the CRP concentration, A is the sensor response when all
binding sites are occupied, Z is an overall offset to account
for the response to pure buffer, Kd is the dissociation con-
stant, and n is the Hill coefficient describing cooperativity of
binding. To construct the fit, the maximum response A was
constrained to a value (A¼ 77.3%) that was based on the
observed response data and all other parameters, e.g., Kd, Z,
and n were allowed to vary. The best-fit parameters were
Kd¼ 0.316 0.13 lgml1 (2.6 nM), Z¼ 8.16 3.4%, and
n¼ 0.556 0.03. The low Kd value is an indicative of strong
anti-CRP binding to target CRP analyte on the sensor device,
which in turn reflected the high anti-CRP loading on
PAMAM dendrimer at the SWNT network FET device. A
low value of n¼ 0.55 corresponds to negative cooperativity,
which may be due to inhibition of multiple CRP molecules
binding to small aggregates or clusters of anti-CRP due to
steric hindrance. The offset parameter Z¼ 8.16 3.4% was in
good agreement with the measured responses of devices to
pure buffer (DI/I¼ 8.86 1.5%; see Fig. 3). The data presenta-
tion in Fig. 3 shows that the measured responses could be
used to sufficiently differentiate between the pure buffer (DI/I
¼ 8.8%) and buffer containing CRP at a concentration of as
low as 0.01lg ml1, or 85 pM (DI/I¼ 18.5%). The changes
in current response of the device are about 20% per decade
concentration of the CRP (i.e., 2.0% current change in lA
current signal for every 1.0% increase in CRP concentration).
The sensitivity of the device for the same CRP concentration
is much higher than various other material based FET devi-
ces.20,21 A comparatively 10 fold higher sensitivity obtained
with the PAMAM based device with respect to the recently
reported22 bare SWNT-FET for the same concentration of
CRP signifies the role using PAMAM for effective biomolec-
ular immobilization of anti-CRP with enhanced loading and a
better probe orientation due to its 3-dimensional polymeric
structure on the SWNT device.
Multiple control experiments were performed to test the
specificity of the device (inset to Fig. 3). A Bio-FET device
was tested against buffer containing 1.0lg ml1 non-specific
myoglobin (Mb) protein, and the resulting response (DI/I
¼ 11.66 2.8%) was found to be nearly close to the device
response to pure buffer (DI/I¼ 8.86 1.5%) and much smaller
than the response obtained for the same concentration of spe-
cific CRP (DI/I¼ 58.96 7.8%), indicating towards an almost
no interaction between the anti-CRP and Mb on the SWNT-
FET device (inset of Fig. 3). The response of the FET device
without anti-CRP immobilization (negative control) to 1.0lg
ml1 CRP analyte (DI/I¼ 10.36 1.6%) was again found to
be nearly comparable to the buffer response, indicating that
the non-specific sites on the SWNT network were completely
covered by the Tween-20 (blocking reagent), which prohib-
ited the undesired reaction with the CRP analyte on the
SWNT surface. This suggested a specific CRP analyte–anti-
CRP binding on the SWNT-FET device with a negligible con-
tribution from nonspecific binding.
In conclusion, we have demonstrated a PAMAM den-
drimer modified interdigitated SWNT-FET array device bio-
functionalized with anti-CRP protein for the detection of
CRP analyte. The device exhibited a concentration depen-
dent response over a concentration range of 0.01lg ml1 to
10 lg ml1 CRP in PBS that was in excellent quantitative
agreement with a model based on the Hill–Langmuir equa-
tion of equilibrium thermodynamics. Multiple control
experiments revealed that the anti-CRP immobilized on
PAMAM retains its highly specific binding characteristics
towards CRP analyte when attached to the SWNT network
channel of the FET device. The high sensitivity of the
PAMAM modified SWNT-FET device towards CRP than
the previously reported22 sensor based on the bare SWNT
device signifies the suitability of PAMAM for biomolecular
immobilization with high loading and better probe orienta-
tion. These results of high antigen–antibody specificity with
high sensitivity over the physiological range of CRP concen-
tration and ease of use with a small sample volume make it
superior to traditional immunoassay, suggesting that this
device concept may be used as a portable tool to help diag-
nose disease after a further suitable optimization with real
clinical (blood/human serum/plasma) samples.
See supplementary material for AFM images of
PAMAM modified SWNT-FET device (Fig. S1) and a brief
description of Current–gate voltage (I–Vg) characteristics of
the SWNT-FET devices after each successive modification
steps (Fig. S2).
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FIG. 3. The calibration curve of the Bio-FET device showing percentage
decrease in the current response (DI/I) as a function of CRP concentration.
The data are fit to a model based on the Hill–Langmuir equation (red curve);
the inset shows the comparison of device responses for multiple control
experiments. The Bio-FET device responses to 1.0lg ml1 CRP (light blue
bar), pure PBS buffer (red bar), to a non-specific protein marker 1.0lg ml1
myoglobin (Mb; dark blue bar), and a negative control response of the
device without anti-CRP immobilization to 1.0lg ml1 CRP (green bar).
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